TNF and myeloid sarcoma: Of note, in a large cohort of MS patients, the same investigators showed that CSF levels of TNF and sTNF-R1 at the time of diagnosis correlated with new white and grey matter lesions, increased EDSS score, and evidence of disease activity after 2 years [3].